Stirling Griff (SA, Nick Xenophon Team) Share this | Hansard source

Does that actually mean that the high-strength vaccine will effectively be registered—unlike last year, when the issue was that because companies hadn't registered it it wasn't approved? Will it be actually registered ahead of any company application to ensure that it is definitely available for over 65s?